Event : Why Post-market Pharmacovigilance trials are increasingly seen : What do they tell us and why are they important? http://www.rsc.org/events/detail/6061/Why%20Post-market%20Pharmacovigilance%20trials%20are%20increasingly%20seen%20%3a%20What%20do%20they%20tell%20us%20and%20why%20are%20they%20important%3f This is a feed for event : Why Post-market Pharmacovigilance trials are increasingly seen : What do they tell us and why are they important? Thu, 11 Sep 2014 13:13:13 +0100 6061 6061 http://www.rsc.org/events/detail/6061/Why%20Post-market%20Pharmacovigilance%20trials%20are%20increasingly%20seen%20%3a%20What%20do%20they%20tell%20us%20and%20why%20are%20they%20important%3f Why Post-market Pharmacovigilance trials are increasingly seen : What do they tell us and why are they important? Event dates: 23 August 2011<br/>Event summary: FDA-mandated post-market studies are coming. Phase IV studies are likely to be complex in design and large in scale (possibly 500,000 patients per arm), with exacting endpoints, and obligatory. The <br/>Event Venue: Online Webinar, Houston, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00